| RS2151464836 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151464837 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151466201 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2151466223 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151466235 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis-Noonan syndrome, Neurofibromatosis-Noonan syndrome |
| RS2151466252 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151466254 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151466262 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151466274 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151466279 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151466305 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151466366 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151466475 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151466481 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151466498 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151466537 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151466553 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS2151469964 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151470069 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151470076 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151470108 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151470150 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151470179 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151470201 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151470213 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151470332 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151470350 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151478908 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS2151479069 |
ACSF3
|
Health Risk |
Pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS2151480775 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151481415 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151482554 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151483315 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2151483991 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lymphangiomyomatosis |
| RS2151485506 |
SLC13A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS2151485510 |
SLC13A5
|
Health Risk |
Pathogenic |
— |
| RS2151485792 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2151487481 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2151490072 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2151491863 |
FOXN1
|
Health Risk |
Likely pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2151492087 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2151493215 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2151495220 |
SLC13A5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS2151496734 |
CTC1
|
Health Risk |
Likely pathogenic |
— |
| RS2151497970 |
FOXN1
|
Health Risk |
Likely pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2151498933 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2151498964 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2151499024 |
FOXN1
|
Health Risk |
Likely pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2151499042 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell lymphopenia, infantile |
| RS2151499311 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2151502269 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2151503544 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2151503678 |
CTC1
|
Health Risk |
Pathogenic |
— |
| RS2151504167 |
STUB1
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia 48, Spinocerebellar ataxia 48 |
| RS2151504209 |
STUB1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia 48, Spinocerebellar ataxia 48 |
| RS2151504570 |
STUB1
|
Health Risk |
Pathogenic |
— |
| RS2151505158 |
STUB1
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia 48, Spinocerebellar ataxia 48 |
| RS2151506687 |
JMJD8;STUB1
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS2151507049 |
STUB1
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia 48, Spinocerebellar ataxia 48 |
| RS2151507113 |
STUB1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2151508864 |
CTC1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2151509277 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2151510946 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2151511838 |
CHMP1A
|
Health Risk |
Likely pathogenic |
Pontoneocerebellar hypoplasia, Pontoneocerebellar hypoplasia |
| RS2151511848 |
PIGS
|
Health Risk |
Pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 18, Glycosylphosphatidylinositol biosynthesis defect 18 |
| RS2151512054 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2151512076 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 4, Autosomal recessive polycystic kidney disease |
| RS2151512212 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2151512451 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2151512520 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2151512637 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151513295 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2151513326 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS2151516798 |
CHMP1A
|
Health Risk |
Pathogenic |
— |
| RS2151520224 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151520497 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151520544 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151521044 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151521127 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS2151521778 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2151522509 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151522778 |
CTC1
|
Health Risk |
Likely pathogenic |
— |
| RS2151523516 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151523798 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2151524044 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151524091 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151524168 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2151524944 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151526348 |
TSC2
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS2151529577 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151530716 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2151530795 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2151531785 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2151534791 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151536071 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151536718 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151537459 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151537475 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151537536 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151537542 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |